NEW YORK, May 8, 2020 /PRNewswire/ -- Halper Sadeh
LLP, a global investor rights law firm, announces the filing of a
shareholder class action lawsuit against Progenics Pharmaceuticals,
Inc. (NASDAQ: PGNX) in connection with the proposed merger
between Progenics and Lantheus Holdings, Inc. The lawsuit seeks
damages and/or equitable relief on behalf of Progenics shareholders
under the federal securities laws.
If you are a Progenics shareholder and would like to join the
action or discuss your legal rights and options, please
visit Progenics Class Action or contact
Daniel Sadeh or Zachary Halper, free of charge, at (212)
763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.
The lawsuit alleges that Defendants issued a materially
misleading registration statement recommending that Progenics
shareholders vote in favor of the proposed merger between Progenics
and Lantheus. According to the complaint, the registration
statement contains materially incomplete and misleading information
concerning, among other things, Progenics' financial projections
and the analyses performed by Progenics' financial
advisor.
If you wish to serve as lead plaintiff, you must move the Court
no later than June 22, 2020. A lead
plaintiff is a representative party acting on behalf of other class
members in directing the litigation. If you would like to join
the action or discuss your legal rights and options, please
visit https://halpersadeh.com/actions/progenics-pharmaceuticals-inc-pgnx-stock-merger-lantheus/
or contact Daniel Sadeh or
Zachary Halper, free of
charge, at (212) 763-0060 or sadeh@halpersadeh.com or
zhalper@halpersadeh.com.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE OR YOU MAY REMAIN
AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT.
Halper Sadeh LLP represents investors all over the world who
have fallen victim to securities fraud and corporate misconduct.
Our attorneys have been instrumental in implementing corporate
reforms and recovering millions of dollars on behalf of defrauded
investors.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/progenics-class-action-halper-sadeh-llp-announces-filing-of-shareholder-class-action-lawsuit-against-progenics-pharmaceuticals-inc-investors-are-encouraged-to-contact-the-firm-301056029.html
SOURCE Halper Sadeh LLP
